Upstream Bio
生物技术研究
Waltham，Massachusetts 5,850 位关注者
Developing treatments for inflammatory diseases
Leadership Team
About Us
We are advancing verekitug, a clinical-stage monoclonal antibody targeting an upstream driver of inflammatory response. Our experienced team is committed to leveraging verekitug’s unique mechanism of action to improve the treatment options for millions of patients living with severe inflammatory diseases.
Check Out Our WebsiteWe are upbeat about the future for patients. Join us and be part of it.
Join us in our mission to develop verekitug to be the first approved antagonist of the TSLP receptor to benefit patients suffering from severe inflammatory diseases that are underserved by today’s standard of care. We are looking for passionate and experienced professionals to fill a variety of roles at Upstream. We are a small and nimble team that embraces the pursuit of novel scientific solutions and a collaborative working environment.
Check Out Our Open RolesUpstream Bio Values
At Upstream we value dedication to our patients and are tenacious in our pursuit to conquer inflammatory disease. We harness our diverse roots to fuel our success while working together with accountability, transparency and trust and do what's right, not what is fast or easy.